These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Masai R, Wakui H, Togashi M, Maki N, Ohtani H, Komatsuda A, Sawada K. Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545 [Abstract] [Full Text] [Related]
16. [Light-chain nephropathy]. Iványi B, Nagy J, Varga G, Búzás E. Orv Hetil; 1990 Aug 19; 131(33):1791-5. PubMed ID: 2119026 [Abstract] [Full Text] [Related]
17. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J, Schmaldienst S, Dekker F, Verrina E, Jager KJ. Nephrol Dial Transplant; 2010 Apr 19; 25(4):1200-6. PubMed ID: 20037169 [Abstract] [Full Text] [Related]